Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19

Okasha et al., NCT04361318, NCT04361318, Dec 2020

HCQ for COVID-19

1st treatment shown to reduce risk in March 2020, now with p < 0.0000000001 from 426 studies, used in 59 countries.

No treatment is 100% effective.
Protocols combine treatments.

Estimated 100 patient HCQ early treatment RCT with results not reported over 5 years after estimated completion.
37 HCQ RCTs have results missing long after expected1-37
The trials report a total of 20,499 patients, with 12 trials having actual enrollment of 3,639, and the remainder estimated.
Okasha et al., 31 Dec 2020, Double Blind Randomized Controlled Trial, trial NCT04361318 (history).